This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
CRA surveyed 36 MedTech leaders to understand their strategic priorities and the impact of COVID-19 on their business.
Survey respondents work in leadership positions in major companies including Abbott, Boston Scientific, Depuy, Medtronic, Olympus, Philips Healthcare, Roche, Smith & Nephew, Zimmer-Biomet, and more.
Download the output summary here:
Digital therapeutics (DTx) leverage technology to deliver evidence-based treatments for various health conditions, aiming to complement or replace traditional...
At the end of 2019, the Digital Healthcare Act (Digitales Versorgungsgesetz, DVG) introduced a dedicated pathway enabling reimbursement of digital health...
